Business
PDMR Shareholding / Share Incentive Plan
PDMR Shareholding / Share Incentive Plan.
About this update from Diaceutics Plc
[{"type":"text","content":"\n \n \n \n \n \n 3 April 2023\n \n \n \n Diaceutics PLC\n \n \n \n \n (\"Diaceutics\" or \"the Company\")\n \n \n \n \n \n \n \n \n \n PDMR Shareholding/Share Incentive Plan\n \n \n \n \n \n \n \n \n \n \n Diaceutics PLC\n \n \n , (\n AIM: DXRX),\n a leading technology and solutions provider to the pharmaceutical industry, has been notified that on 28 March 2023, Global Shares Trustees (UK) Limited andZedra Trust Company (Guernsey) Limited, the trustees of the Global Diaceutics plc 2020 Employee Benefit Trust, have purchased ordinary shares (\"Shares\") on behalf of Susanne Munksted, Jordan Clark, Julie Browne and Nick Roberts (PDMRs), in respect of their purchase of Shares pursuant to the Company's UK and Global Share Incentive Plan (\"the SIP Schemes\") for employees. These purchases will be made each month until further notice.\n \n \n \n \n In accordance with the SIP Schemes, the Company has matched these purchases with a matched share award over an equivalent number of Shares purchased by the employee, in the proportion of 1:1.\n \n \n \n \n \n \n \n \n \n Enquiries:\n \n \n \n \n \n \n \n \n \n \n \n \n \n Diaceutics PLC\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Nick Roberts, Chief Financial Officer \n \n \n \n \n Via Alma PR \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Stifel Nicolaus Europe Limited (Nomad & Broker)\n \n \n \n \n \n Tel: +44 (0)20 7710 7600\n \n \n \n \n \n \n Ben Maddison\n \n \n \n \n \n \n \n \n \n \n \n \n \n Nicholas Harland\n \n \n \n \n \n \n \n \n \n \n \n \n \n Nick Adams\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Alma PR\n \n \n \n \n \n Tel: +44(0)20 3405 0205\n \n \n \n \n \n \n Caroline Forde\n \n \n \n \n [email protected]\n \n \n \n \n \n \n Kieran Breheny\n \n \n \n \n \n \n \n \n \n \n \n \n \n Matthew Young\n \n \n Kinvara Verdon\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n About Diaceutics\n \n \n \n \n \n \n \n \n At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world's leading pharmaceutical and life science companies with solutions and technology for the commercialisation of the...